News

AIS2018

AIS 2018 : TARGETS FOR MABS INNOVATIVE APPROACHES FOR THEIR DISCOVERY & VALIDATION

Read more

Sans titre

MASTER CLASSES DE L’IMMUNOTHÉRAPIE

Read more

Recruitment, recruit, recruiter.

Development of new immunoconjugates for HER2-positive breast cancers

Read more

bandeau-carré-AIS2017

Assises 2017: Antibody-Drug Conjugates

Read more